Elanco Animal Health Inc (FRA:5EA)
€ 15.684 0.166 (1.07%) Market Cap: 7.73 Bil Enterprise Value: 12.71 Bil PE Ratio: 0 PB Ratio: 1.40 GF Score: 66/100

Elanco Animal Health Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2020 / 07:00PM GMT
Release Date Price: €20.6 (-1.90%)
Nathan Allen Rich
Goldman Sachs Group, Inc., Research Division - Research Analyst

My name is Nathan Rich, and I cover the animal health space here at Goldman. We're very pleased today to introduce our next session with Elanco and the company's President and CEO, Jeff Simmons; and Todd Young, the company's CFO.

We're going to start the session today with some prepared remarks from Jeff, and then we'll get into the Q&A.

Before we get started, I'd just like to remind everyone that if anyone would like to ask a question during the course of this session, you can do so either through the webcast or by sending an e-mail to myself at [email protected], and we'll try to get to your question.

So with that, Jeff and Todd, thanks so much for joining us today.

Jeffrey N. Simmons
Elanco Animal Health Incorporated - President, CEO & Director

Great. Thank you, Nathan. I think given the technology, it will primarily be me, but if we needed to bring Todd in, we could. So let me just open real quick, like just with a brief maybe 1-minute

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot